Intermed Labs garnered the honor for its Fingy3D device, a 3D-printed finger prosthetic. The award came with a $10,000 prize to advance the project. The device will soon begin a pilot trial at Seattle-based University of Washington and Atlanta-based Emory University.
“Intermed Labs at Mon Health has created the startup environment needed for innovators to succeed globally, as evidenced by industry leaders visiting Morgantown, using our products, and evaluating our future innovations,” said David Goldberg, president and CEO of Mon Health and executive vice president of parent system Vandalia Health, in a Nov. 3 Mon Health news release. “I have no doubt that we can build a flourishing medtech ecosystem within the state.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.